Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Bayer Eyes Indications Beyond BlueRock's Initial Focus With $240m-Plus Buyout
Aug 09 2019
•
By
Mandy Jackson
Bayer will oversee the company's operations, but maintain BlueRock's entrepreneurial nature. • Source: Shutterstock
More from Deals
More from Business